255 related articles for article (PubMed ID: 25525303)
21. Glycogen synthase kinase-3β inhibition induces nuclear factor-κB-mediated apoptosis in pediatric acute lymphocyte leukemia cells.
Hu Y; Gu X; Li R; Luo Q; Xu Y
J Exp Clin Cancer Res; 2010 Nov; 29(1):154. PubMed ID: 21110852
[TBL] [Abstract][Full Text] [Related]
22. Anti-dengue virus nonstructural protein 1 antibodies cause NO-mediated endothelial cell apoptosis via ceramide-regulated glycogen synthase kinase-3β and NF-κB activation.
Chen CL; Lin CF; Wan SW; Wei LS; Chen MC; Yeh TM; Liu HS; Anderson R; Lin YS
J Immunol; 2013 Aug; 191(4):1744-52. PubMed ID: 23851680
[TBL] [Abstract][Full Text] [Related]
23. Glycogen synthase kinase 3beta-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor kappaB signaling.
Sanchez JF; Sniderhan LF; Williamson AL; Fan S; Chakraborty-Sett S; Maggirwar SB
Mol Cell Biol; 2003 Jul; 23(13):4649-62. PubMed ID: 12808104
[TBL] [Abstract][Full Text] [Related]
24. New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9.
Lee CS; Kwon YW; Yang HM; Kim SH; Kim TY; Hur J; Park KW; Cho HJ; Kang HJ; Park YB; Kim HS
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):472-9. PubMed ID: 19201691
[TBL] [Abstract][Full Text] [Related]
25. Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma.
Tang QL; Xie XB; Wang J; Chen Q; Han AJ; Zou CY; Yin JQ; Liu DW; Liang Y; Zhao ZQ; Yong BC; Zhang RH; Feng QS; Deng WG; Zhu XF; Zhou BP; Zeng YX; Shen JN; Kang T
J Natl Cancer Inst; 2012 May; 104(10):749-63. PubMed ID: 22534782
[TBL] [Abstract][Full Text] [Related]
26. Beneficial role of oleuropein in sepsis-induced myocardial injury. Possible Involvement of GSK-3β/NF-kB pathway.
Xing C; Xu L; Yao Y
Acta Cir Bras; 2021; 36(1):e360107. PubMed ID: 33605309
[TBL] [Abstract][Full Text] [Related]
27. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.
Hoeflich KP; Luo J; Rubie EA; Tsao MS; Jin O; Woodgett JR
Nature; 2000 Jul; 406(6791):86-90. PubMed ID: 10894547
[TBL] [Abstract][Full Text] [Related]
28. Glycogen synthase kinase-3beta inhibitors protect against the organ injury and dysfunction caused by hemorrhage and resuscitation.
Dugo L; Abdelrahman M; Murch O; Mazzon E; Cuzzocrea S; Thiemermann C
Shock; 2006 May; 25(5):485-91. PubMed ID: 16680013
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of glycogen synthase kinase 3 beta attenuates neurocognitive dysfunction resulting from cranial irradiation.
Thotala DK; Hallahan DE; Yazlovitskaya EM
Cancer Res; 2008 Jul; 68(14):5859-68. PubMed ID: 18632640
[TBL] [Abstract][Full Text] [Related]
30. Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone.
Ban JO; Kwak DH; Oh JH; Park EJ; Cho MC; Song HS; Song MJ; Han SB; Moon DC; Kang KW; Hong JT
Chem Biol Interact; 2010 Oct; 188(1):75-85. PubMed ID: 20540935
[TBL] [Abstract][Full Text] [Related]
31. [Role of glycogen synthase kinase 3β in maturation and function of murine myeloid dendritic cells in vitro].
Chu S; Li H; Li X; Kang X; Huang Q; Wang H; Qiu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1809-14. PubMed ID: 26714922
[TBL] [Abstract][Full Text] [Related]
32. Atorvastatin Alleviates Experimental Diabetic Cardiomyopathy by Regulating the GSK-3β-PP2Ac-NF-κB Signaling Axis.
Ren XM; Zuo GF; Wu W; Luo J; Ye P; Chen SL; Hu ZY
PLoS One; 2016; 11(11):e0166740. PubMed ID: 27851811
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of GSK-3β induces AP-1-mediated osteopontin expression to promote cholestatic liver fibrosis.
Zhuang S; Hua X; He K; Zhou T; Zhang J; Wu H; Ma X; Xia Q; Zhang J
FASEB J; 2018 Aug; 32(8):4494-4503. PubMed ID: 29529390
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of glycogen synthase kinase-3β attenuates organ injury and dysfunction associated with liver ischemia-reperfusion and thermal injury in the rat.
Rocha J; Figueira ME; Barateiro A; Fernandes A; Brites D; Pinto R; Freitas M; Fernandes E; Mota-Filipe H; Sepodes B
Shock; 2015 Apr; 43(4):369-78. PubMed ID: 25394244
[TBL] [Abstract][Full Text] [Related]
35. Glycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradation.
Neumann M; Klar S; Wilisch-Neumann A; Hollenbach E; Kavuri S; Leverkus M; Kandolf R; Brunner-Weinzierl MC; Klingel K
Oncogene; 2011 May; 30(21):2485-92. PubMed ID: 21217772
[TBL] [Abstract][Full Text] [Related]
36. Glycogen synthase kinase-3 facilitates con a-induced IFN-γ-- mediated immune hepatic injury.
Tsai CC; Huang WC; Chen CL; Hsieh CY; Lin YS; Chen SH; Yang KC; Lin CF
J Immunol; 2011 Oct; 187(7):3867-77. PubMed ID: 21873526
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of GSK3 differentially modulates NF-kappaB, CREB, AP-1 and beta-catenin signaling in hepatocytes, but fails to promote TNF-alpha-induced apoptosis.
Götschel F; Kern C; Lang S; Sparna T; Markmann C; Schwager J; McNelly S; von Weizsäcker F; Laufer S; Hecht A; Merfort I
Exp Cell Res; 2008 Apr; 314(6):1351-66. PubMed ID: 18261723
[TBL] [Abstract][Full Text] [Related]
38. Ionizing radiation can induce GSK-3beta phosphorylation and NF-kappaB transcriptional transactivation in ATM-deficient fibroblasts.
Kwon O; Kim KA; He L; Kim SO; Kim MS; Cha EY; Yoon BD; Sok DE; Jung M; Ahn JS; Kim BY
Cell Signal; 2008 Apr; 20(4):602-12. PubMed ID: 18243662
[TBL] [Abstract][Full Text] [Related]
39. Diabetes Worsens Ischemia-Reperfusion Brain Injury in Rats Through GSK-3β.
Liu H; Ou S; Xiao X; Zhu Y; Zhou S
Am J Med Sci; 2015 Sep; 350(3):204-11. PubMed ID: 26226547
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of glycogen synthase kinase-3β by lithium chloride suppresses 6-hydroxydopamine-induced inflammatory response in primary cultured astrocytes.
Wang HM; Zhang T; Li Q; Huang JK; Chen RF; Sun XJ
Neurochem Int; 2013 Nov; 63(5):345-53. PubMed ID: 23871716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
